CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.8799
+0.0099 (1.14%)
Oct 16, 2026, 4:00 PM EDT - Market closed
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $10.5 million as of October 16, 2026. It is the 41,360th most valuable company in the world and the 5,589th biggest in the United States. Its market cap has decreased by 59.56% in one year.
Market Cap
10.50M
Enterprise Value
9.73M
1-Year Change
-59.56%
Global Rank
Country Rank
#5,589 United States
Category
ChartMarket Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $10.50M, a decrease of -77.23%. That is a compound annual growth rate of -34.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 10.50M | -31.83% |
| Dec 31, 2025 | 15.41M | -60.74% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Passage Bio | 11.58M |
| Cellectar Biosciences | 11.25M |
| Intensity Therapeutics | 11.04M |
| Phio Pharmaceuticals | 10.76M |
| BioLineRx | 10.59M |
| Purple Biotech | 10.54M |
| Tempest Therapeutics | 10.50M |
| Theriva Biologics | 9.73M |